🔎 Trials Near Me

Home › Osteosarcoma › Massachusetts › Boston

Pag-aaral pangklinika para sa Osteosarcoma sa Boston, MA

9 pag-aaral para sa Osteosarcoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Boston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Nagre-recruitPhase 2
  • Dana-Farber Cancer Institute, Boston
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2
  • Dana-Farber Cancer Institute, Boston
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Nagre-recruitPhase 3
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165

SPEARHEAD-3 Pediatric Study

Nagre-recruitPhase 1/2
  • Dana Farber Cancer Institute, Boston
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Nagre-recruitPhase 1/2
  • Dana Farber Cancer Institute, Boston
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral
  • Dana-Farber Cancer Institute, Boston
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Nagre-recruitPhase 1/2
  • Dana Farber Cancer Institute, Boston
Edad 12 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT07357519

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Nagre-recruitPhase 2
  • Dana-Farber Cancer Institute, Boston
Edad 12 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT05019703

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Nagre-recruitPhase 1/2
  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
Edad 12 hanggang 49 · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT06709495

Pag-aaral para sa Osteosarcoma sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.